All Stories

  1. Evaluations of FDA-approved Drugs Targeting 3CLP of SARS-CoV-2 Employing a Repurposing Strategy

    Article • Combinatorial Chemistry & High Throughput Screening, December 2024, Bentham Science Publishers

    Syed Sayeed Ahmad

  2. Strategic Approaches to Target the Enzymes using Natural Compounds for the Management of Alzheimer’s Disease: A Review

    Article • CNS & Neurological Disorders - Drug Targets, August 2022, Bentham Science Publishers

    Syed Sayeed Ahmad, Mr Kaiser Younis, Professor HAROON N KHAN

  3. Study of Nutraceuticals and Phytochemicals for the Management of Alzheimer's Disease: A Review

    Article • Current Neuropharmacology, November 2021, Bentham Science Publishers

    Syed Sayeed Ahmad, Prof. MA Kamal, Mr Kaiser Younis

  4. Diabetic Cardiomyopathy: From Mechanism to Management in a Nutshell

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, February 2021, Bentham Science Publishers

    Syed Sayeed Ahmad, Shahzad Khan, Prof. MA Kamal

  5. Ajmalicine and its Analogues Against AChE and BuChE for the Management of Alzheimer’s Disease: An In-silico Study

    Article • Current Pharmaceutical Design, October 2020, Bentham Science Publishers

    Syed Sayeed Ahmad, Prof. MA Kamal, Mohammad khalid

  6. The Language Development Via FOXP2 in Autism Spectrum Disorder: A Review

    Article • Current Pharmaceutical Design, October 2020, Bentham Science Publishers

    Syed Sayeed Ahmad, Prof. MA Kamal

  7. Screening of Metal and Antibiotic Resistance in Beta-lactamase Producing Coliform Bacteria from Hospital Wastewater of Northern India

    Article • Recent Patents on Biotechnology, January 2020, Bentham Science Publishers

    Manzar Alam, Syed Sayeed Ahmad

  8. The Structure and Function of α, β and γ-Secretase as Therapeutic Target Enzymes in the Development of Alzheimer’s Disease: A Review

    Article • CNS & Neurological Disorders - Drug Targets, January 2020, Bentham Science Publishers

    Syed Sayeed Ahmad, Prof. MA Kamal, Shahzad Khan

  9. Therapeutic Study of Phytochemicals Against Cancer and Alzheimer’s Disease Management

    Article • Current Drug Metabolism, January 2020, Bentham Science Publishers

    Syed Sayeed Ahmad, Prof. MA Kamal

  10. NMR: From molecular mechanism to its application in medical care

    Article • Medicinal Chemistry, November 2019, Bentham Science Publishers

    Syed Sayeed Ahmad

  11. Interaction study of dietary fibers (pectin and cellulose) with meat proteins using bioinformatics analysis: An In-Silico study

    Article • LWT, November 2019, Elsevier

    Syed Sayeed Ahmad

  12. Concept of Drug Metabolism in Drug Discovery Pipeline

    Article • Current Drug Metabolism, October 2019, Bentham Science Publishers

    Syed Sayeed Ahmad

  13. Computational Study of Natural Compounds for the Clearance of Amyloid-Βeta: A Potential Therapeutic Management Strategy for Alzheimer’s Disease

    Article • Molecules, September 2019, MDPI AG

    Syed Sayeed Ahmad, Professor HAROON N KHAN

  14. What is Blockchain Technology and its Significance in the Current Healthcare System? A Brief Insight

    Article • Current Pharmaceutical Design, August 2019, Bentham Science Publishers

    Syed Sayeed Ahmad

  15. Current updates on the regulation of beta-secretase movement as a potential restorative focus for management of Alzheimer`s disease

    Article • Protein and Peptide Letters, April 2019, Bentham Science Publishers

    Syed Sayeed Ahmad

  16. From Molecular Mechanism to the Etiology of Sjogren Syndrome

    Article • Current Pharmaceutical Design, January 2019, Bentham Science Publishers

    Syed Sayeed Ahmad, Prof. MA Kamal

  17. Screening and Elucidation of Selected Natural Compounds for Anti- Alzheimer's Potential Targeting BACE-1 Enzyme: A Case Computational Study

    Article • Current Computer - Aided Drug Design, November 2017, Bentham Science Publishers

    Prof. MA Kamal, Dr. Salman Akhtar, Syed Sayeed Ahmad

  18. Multiple Targets for the Management of Alzheimer’s Disease

    Article • CNS & Neurological Disorders - Drug Targets, October 2016, Bentham Science Publishers

    Syed Sayeed Ahmad

  19. Prediction of Comparative Inhibition Efficiency for a Novel Natural Ligand, Galangin Against Human Brain Acetylcholinesterase, Butyrylcholinesterase and 5-Lipoxygenase: A Neuroinformatics Study

    Article • CNS & Neurological Disorders - Drug Targets, May 2014, Bentham Science Publishers

    Dr Shams Tabrez, Dr. Sibhghatulla Shaikh, Syed Sayeed Ahmad

  20. Molecular Interaction of Human Brain Acetylcholinesterase with a Natural Inhibitor Huperzine-B: An Enzoinformatics Approach

    Article • CNS & Neurological Disorders - Drug Targets, May 2014, Bentham Science Publishers

    Dr. Sibhghatulla Shaikh, Syed Sayeed Ahmad

  21. Current Acetylcholinesterase-Inhibitors: A Neuroinformatics Perspective

    Article • CNS & Neurological Disorders - Drug Targets, May 2014, Bentham Science Publishers

    Dr Shams Tabrez, Dr. Sibhghatulla Shaikh, Syed Sayeed Ahmad